Fibrotic focus and hypoxia in male breast cancer

Modern Pathology

Volumn 25, Issue 10, 2012, Pages 1397-1404

  Kornegoor, Robert ^a   Verschuur Maes, Anoek H J ^a   Buerger, Horst ^b   Hogenes, Marieke C H ^c   De Bruin, Peter C ^d   Oudejans, Joost J ^e   Hinrichs, Bernd ^f   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Institute of Pathology   (Germany)

^c Laboratory for Pathology East Netherlands   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e DEPARTMENT OF SURGERY   (Netherlands)

^f Center of Pathology and Cytodiagnostic   (Germany)

Author keywords

fibrotic focus; hypoxia; male breast cancer; prognosis

Indexed keywords

CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST FIBROSIS; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; MITOSIS RATE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BREAST NEOPLASMS, MALE; CARBONIC ANHYDRASES; CARCINOMA, DUCTAL, BREAST; CELL HYPOXIA; FIBROSIS; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84866973552     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.101     Document Type: Article

References (39)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Anderson WF, Jatoi I, Tse J, et al. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2010;28:232-239.
3. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 2003;127:36-41. (Pubitemid 36236577)
4. Andre S, Pinto AE, Laranjeira C, et al. Male and female breast cancer-differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis. Pathobiology 2007;74:323-327. (Pubitemid 350273703)
5. Johansson I, Nilsson C, Berglund P, et al. Highresolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat 2010; 129:747-760.
6. Callari M, Cappelletti V, De Cecco L, et al. Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat 2010;127:601-610.
7. Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996;77:490-498. (Pubitemid 26047570)
8. Marchal F, Salou M, Marchal C, et al. Men with breast cancer have same disease-specific and event-free survival as women. Ann Surg Oncol 2009;16:972-978.
9. Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population-based study. Cancer 2004;101:51-57. (Pubitemid 38812422)
10. Cutuli B, Le-Nir CC, Serin D, et al. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol 2010;73:246-254.
11. Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat 1998;49:195-208. (Pubitemid 28416785)
12. Hasebe T, Sasaki S, Imoto S, et al. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 2002;15:502-516. (Pubitemid 34521399)
13. Colpaert C, Vermeulen P, Jeuris W, et al. Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 2001;193:442-449. (Pubitemid 32266812)
14. Colpaert C, Vermeulen P, van Beest P, et al. Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology 2001;39:416-425. (Pubitemid 32990095)
15. Baak JP, Colpaert CG, van Diest PJ, et al. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers. Eur J Cancer 2005;41:2093-2101. (Pubitemid 41337951)
16. Van den Eynden GG, Colpaert CG, Couvelard A, et al. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology 2007;51: 440-451. (Pubitemid 47437821)
17. Nishimura R, Hasebe T, Tsubono Y, et al. The fibrotic focus in advanced colorectal carcinoma: a hitherto unrecognized histological predictor for liver metastasis. Virchows Arch 1998;433:517-522. (Pubitemid 28561183)
18. Maeshima AM, Niki T, Maeshima A, et al. Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma. Cancer 2002;95:2546-2554. (Pubitemid 35424041)
19. Couvelard A, O0Toole D, Leek R, et al. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology 2005;46: 668-676. (Pubitemid 40834826)
20. Colpaert CG, Vermeulen PB, Fox SB, et al. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res Treat 2003;81:137-147. (Pubitemid 37211131)
21. Van den Eynden GG, Van der Auwera I, Van Laere SJ, et al. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. Br J Cancer 2005;93:1128-1136. (Pubitemid 41670697)
22. Bos R, van der Groep P, Greijer AE, et al. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003;97:1573-1581. (Pubitemid 36297788)
23. Bos R, Zhong H, Hanrahan CF, et al. Levels of hypoxiainducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 2001;93:309-314. (Pubitemid 32219818)
24. Schindl M, Schoppmann SF, Samonigg H, et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002;8: 1831-1837. (Pubitemid 34633742)
25. Vleugel MM, Greijer AE, Shvarts A, et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 2005;58:172-177. (Pubitemid 40193803)
26. Chia SK, Wykoff CC, Watson PH, et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001;19:3660-3668. (Pubitemid 32786278)
27. Kornegoor R, Verschuur-Maes AH, Buerger H, et al. Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol 2012;25:398-404.
28. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19: 403-410.
29. van Diest PJ, Baak JP, Matze-Cok P, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 1992;23: 603-607.
30. van der Groep P, Bouter A, Menko FH, et al. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. Breast Cancer Res Treat 2008; 111:475-480.
31. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47. (Pubitemid 37328806)
32. Bos R, van Diest PJ, de Jong JS, et al. Hypoxiainducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 2005;46:31-36. (Pubitemid 40193695)
33. Hasebe T, Sasaki S, Imoto S, et al. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol 2001;14:325-337. (Pubitemid 32298918)
34. Noel A, Hajitou A, L0Hoir C, et al. Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts. Int J Cancer 1998;76:267-273.
35. Afzal S, Lalani EN, Poulsom R, et al. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998;29:155-165. (Pubitemid 28099511)
36. Hasebe T, Sasaki S, Imoto S, et al. Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast. Am J Pathol 2000;156: 1701-1710. (Pubitemid 30646708)
37. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999;59:5830-5835.
38. Laughner E, Taghavi P, Chiles K, et al. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001;21:3995-4004. (Pubitemid 32476461)
39. van Diest PJ, Vleugel MM, van der Wall E. Expression of HIF-1alpha in human tumours. J Clin Pathol 2005;58:335-336.